• Explore /
  • Poster
  • / Real-world experience of an in-house dihydropyrimidine dehydrogenase (<em>DPYD</em>) genotype test to guide fluoropyrimidine (FP) dosing at a multisite cancer hospital.

Real-world experience of an in-house dihydropyrimidine dehydrogenase (DPYD) genotype test to guide fluoropyrimidine (FP) dosing at a multisite cancer hospital.

Abstract Poster

Authors

null

Jai Narendra Patel

Levine Cancer Institute, Atrium Health, Charlotte, NC

Jai Narendra Patel , Sarah Morris , Grace Nguyen , Karine Eboli Lopes , Alicia Hamilton , Simeon Owuor Kwange , Nury Steuerwald , Donald Moore , Sarah Hanson , Chris Larck , James Thomas Symanowski , Kristen Swift , Laura W. Musselwhite , Kunal C. Kadakia , Brinda Koya , Seungjean Chai , Kwabena Osei-Boateng , Sini Kalapurakal , Jimmy J. Hwang

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Care Delivery and Regulatory Policy

Track

Care Delivery and Quality Care

Sub Track

Care Delivery

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 1534)

DOI

10.1200/JCO.2023.41.16_suppl.1534

Abstract #

1534

Poster Bd #

128

Abstract Disclosures

Similar Posters

First Author: Côme De Metz

First Author: Gabriel Brooks

First Author: Garrett Rompelman

First Author: Gabriel A. Brooks